R. Alexandra Keith Procter & Gamble CO (PG) insider trading activity

R. Alexandra Keith is CEO - Beauty of PROCTER & GAMBLE Co. Currently has a direct ownership of 13,783 shares of PG, which is worth approximately $2.36 Million. The most recent transaction as insider was on Apr 21, 2022, when has been sold 6,854 shares (Common Stock) at a price of $163.5 per share, resulting in proceeds of $1,120,629. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 13.8K

54.52% 3M change

43.6% 12M change

Total Value Held $2.36 Million

R. Alexandra Keith Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 21 2022	SELL Open market or private sale	$1,120,629 $163.5 p/Share	6,854 Reduced 16.46%	34,791 Common Stock
Mar 01 2022	SELL Open market or private sale	$886,827 $153.51 p/Share	5,777 Reduced 12.18%	41,645 Common Stock
Dec 06 2021	SELL Payment of exercise price or tax liability	$12,948 $148.83 p/Share	87 Reduced 0.18%	47,162 Common Stock
Dec 06 2021	BUY Exercise of conversion of derivative security	$12,948 $148.83 p/Share	87 Added 0.18%	47,250 Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	3,412 Added 6.78%	46,884 Common Stock
Aug 19 2021	SELL Open market or private sale	$2,199,911 $143.27 p/Share	15,355 Reduced 26.1%	43,472 Common Stock
Aug 17 2021	SELL Open market or private sale	$1,923,730 $144.37 p/Share	13,325 Reduced 18.47%	58,827 Common Stock
Aug 17 2021	BUY Grant, award, or other acquisition	-	28,680 Added 28.44%	72,152 Common Stock
Aug 02 2021	BUY Grant, award, or other acquisition	-	14,098 Added 24.56%	43,296 Common Stock
Apr 21 2021	SELL Open market or private sale	$1,432,750 $137.99 p/Share	10,383 Reduced 26.35%	29,016 Common Stock
Feb 26 2021	SELL Open market or private sale	$1,180,351 $125.77 p/Share	9,385 Reduced 19.24%	39,399 Common Stock
Dec 15 2020	SELL Payment of exercise price or tax liability	$5,200 $136.85 p/Share	38 Reduced 0.08%	48,523 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$5,200 $136.85 p/Share	38 Added 0.08%	48,561 Common Stock
Oct 21 2020	SELL Open market or private sale	$11,410,875 $143.75 p/Share	79,380 Reduced 62.18%	48,291 Common Stock
Oct 21 2020	BUY Exercise of conversion of derivative security	$6,786,990 $85.5 p/Share	79,380 Added 52.48%	71,864 Common Stock
Oct 01 2020	BUY Grant, award, or other acquisition	-	3,051 Added 5.94%	48,291 Common Stock
Aug 20 2020	SELL Open market or private sale	$2,295,974 $136.09 p/Share	16,871 Reduced 27.16%	45,240 Common Stock
Aug 18 2020	SELL Open market or private sale	$2,081,536 $136.53 p/Share	15,246 Reduced 19.71%	62,111 Common Stock
Aug 18 2020	BUY Grant, award, or other acquisition	-	32,117 Added 29.34%	77,357 Common Stock
Jul 31 2020	SELL Open market or private sale	$3,389,620 $130.0 p/Share	26,074 Reduced 36.68%	45,013 Common Stock
Jul 31 2020	BUY Exercise of conversion of derivative security	$2,050,981 $78.66 p/Share	26,074 Added 26.84%	71,087 Common Stock
Apr 21 2020	SELL Open market or private sale	$883,200 $120.0 p/Share	7,360 Reduced 14.13%	44,746 Common Stock
Feb 28 2020	SELL Open market or private sale	$476,107 $110.44 p/Share	4,311 Reduced 9.55%	40,851 Common Stock
Feb 28 2020	BUY Grant, award, or other acquisition	-	11,255 Added 17.76%	52,106 Common Stock
Feb 27 2020	SELL Open market or private sale	$275,279 $117.49 p/Share	2,343 Reduced 4.93%	45,162 Common Stock

Also insider at

TMO

THERMO FISHER SCIENTIFIC INC. Healthcare

Director

RAK